Sativex, a drug derived from the cannabis plant for multiple sclerosis pain

Canadians will soon be able to get Sativex, a drug derived from the cannabis plant for multiple sclerosis pain.

Canada is the first country to approve this drug.

Interestingly, Canada has one of the highest rates of multiple sclerosis in the world.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote